These findings demonstrate that MAPK/ERK and PI3K/AKT pathway inhibitors promote the generation of intracellular ROS in REH, MOLT-4, and MOLM-14 cells and changes in GSH/GSSG ratio are associated with the leukemia type. This evidence concerns the gene MAPK1 and leukemia.